Eric Lefkofsky’s Tempus New Edition in the Battle against Breast Cancer
Eric Lefkofsky is one of the founding partners and the CEO of Tempus. Tempus is a technical establishment founded to battle cancer through the use of an operating system. He is also the co-founder at several other technology organizations including Lightbank, Groupon (NASDAQ:GRPN), Uptake technologies, Echo Global Logistics (NASDAQ: ECHO), and InnerWorkings (NASDAQ: INWK).MrLefkofsky and his wife Liz established the Lefkofsky Family Foundation back in 2006. The purpose of the organization was to ensure high-impact initiatives that enhanced the lives of individuals it served.Tempus organization recently partnered with the University of Chicago medicine in March 2017. This collaboration is aimed at assisting the doctors at the university with data so that they can offer better breast cancer treatment to patients.
Tempus declares that it will examine data from a thousand breast cancer patients so that it can help medical practitioners to discern patterns that can foresee how the patients will respond to treatment.Dr. OlufunmilayoOlopade, a medic at the University of Chicago, explained in a statement that there is little accessible information on the masses of patients that have battled breast cancer despite it being the most common type of cancer. Consequently, medical practitioners are forced to make treatment decisions in the absence of genetic data that could assist in making better informed and accurately targeted decisions.
The doctor was therefore happy of the new collaboration between the university and Tempus.Tempus incorporates machine learning and genomic sequencing to aid physicians make real-time, personalized treatment decisions. Tempus has collaborated with many other establishments apart from University of Chicago in using data to fight cancer. These include Comprehensive Cancer Center of Northwestern University, Rush University Medical Center, Penn Medicine, University of Michigan, and the Mayo Clinic.